info@heparegenix.com
+49 (0)7071 7912810
Sitemap
Site Notice
Privacy Policy
Home
About us
Investors
Science
Liver diseases face an enormous unmet medical need
MKK4 – A First-in-class Therapeutic Target
Translation into the Clinic
Jobs
News
Contact
Search
Home
About us
Investors
Science
Liver diseases face an enormous unmet medical need
MKK4 – A First-in-class Therapeutic Target
Translation into the Clinic
Jobs
News
Contact
HepaRegenix GmbH
Management
Christoph Enderle
Chief Financial Officer
Back to: About us
